Loading...
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
One of the hallmarks of cancer is sustained angiogenesis. Favorable results have been reported in some breast cancer (BC) patients receiving antiangiogenic therapy with bevacizumab (Bev) in combination with chemotherapy, and further knowledge on how Bev can be optimally combined with conventional tr...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763780/ https://ncbi.nlm.nih.gov/pubmed/31402562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12561 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|